Australia markets open in 3 hours 14 minutes

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.51+0.52 (+4.73%)
At close: 04:00PM EDT
11.60 +0.09 (+0.78%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.99
Bid11.46 x 700
Ask11.52 x 1400
Day's range11.13 - 12.05
52-week range8.79 - 32.10
Avg. volume1,462,158
Market cap552.206M
Beta (5Y monthly)-0.57
PE ratio (TTM)N/A
EPS (TTM)-2.17
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend date13 Dec 2012
1y target est103.00
  • Yahoo Finance Video

    Cassava forms committee after US probe, researcher fraud

    Cassava Sciences (SAVA) is reportedly forming a committee to investigate two senior employees. This comes after a US probe into fraud and a Cassava researcher was indicted by a jury over alleged fabrication of Alzheimer's drug trial results. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.


    Cassava Sciences Shares Plunge on Indictment Against Former Advisor

    A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.

  • GlobeNewswire

    Cassava Sciences Issues Statement on Former Science Advisor

    AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the U.S. National Institutes of Health (NIH). Hoau-Yan Wang was a tenured medical professor at a public university’s medical school as well as a former paid science advisor to Cassava Sciences. According to public court documents, Dr. Wang engaged in illegal behavior to defraud the go